Table 1.
Clinical and demographic characteristics of patients and controls
| Parameters | Patients (n = 55) | Controls (n = 40) | P |
|---|---|---|---|
| Age, years | 70 ± 11 | 67 ± 6.5 | 0.1 |
| Male, n (%) | 41 (74.5%) | 23 (57.5%) | 0.1 |
| Smoker, n (%) | 20 (36%) | 12 (30%) | 0.6 |
| Alcohol | 4 (7.2%) | 1 (2.5%) | 0.3 |
| Family history of heart disease, n (%) | 45 (82%) | 5 (12.5%) | <0.0001 |
| Disease duration, years | 10.6 ± 4.2 | – | – |
| BMI, kg/m2 | 25.3 ± 4.5 | 26.9 ± 3 | 0.2 |
| NYHA class, n (II/III/IV) | 12/28/15 | – | – |
| LVEF, % | 30 ± 12 | – | – |
| BNP, pg/m | 670 ± 571 | – | – |
| Etiology | |||
| Ischemic heart failure, n (%) | 55 (100) | – | – |
| Medications | |||
| Aspirin, % | 38 | – | – |
| Diuretics, % | 21 | – | – |
| ACE inhibitors, % | 32 | – | – |
| Beta-blockers, % | 34 | – | – |
ACE, angiotensin-converting enzyme; BMI, body mass index; BNP, brain natriuretic peptide; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.